Cibus Inc
CBUS1.535USD
+0.045+3.02%
Horário de mercado （ET）Cotações atrasadas em 15 min
50.13MValor de mercado
PerdaP/L TTM
Mais detalhes de Cibus Inc Empresa
Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.
Informações da empresa
Código da empresaCBUS
Nome da EmpresaCibus Inc
Data de listagemJul 20, 2017
CEODr. Peter Ronald Beetham, Ph.D.
Número de funcionários157
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 20
Endereço6455 Nancy Ridge Drive
CidadeSAN DIEGO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92121
Telefone18584500008
Sitehttps://www.cibus.com/
Código da empresaCBUS
Data de listagemJul 20, 2017
CEODr. Peter Ronald Beetham, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
Mr. Jean-Pierre Lehmann
Mr. Jean-Pierre Lehmann
Independent Director
Independent Director
--
--
Mr. Mark Finn
Mr. Mark Finn
Lead Independent Director
Lead Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Detalhamento da receita
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
1.03M
0.00%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Riggs (Rory B)
30.24%
Fidelity Management & Research Company LLC
9.50%
Armistice Capital LLC
4.03%
JPL Investments SA
3.46%
Vantage Consulting Group, Inc.
2.36%
Other
50.40%
Investidores
Investidores
Proporção
Riggs (Rory B)
30.24%
Fidelity Management & Research Company LLC
9.50%
Armistice Capital LLC
4.03%
JPL Investments SA
3.46%
Vantage Consulting Group, Inc.
2.36%
Other
50.40%
Tipos de investidores
Investidores
Proporção
Individual Investor
32.86%
Investment Advisor
14.99%
Investment Advisor/Hedge Fund
4.99%
Hedge Fund
4.12%
Corporation
3.55%
Family Office
0.44%
Research Firm
0.29%
Bank and Trust
0.09%
Other
38.69%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
166
29.51M
61.00%
+13.82M
2025Q1
171
17.83M
39.89%
+256.22K
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Riggs (Rory B)
14.63M
30.24%
+11.68M
+396.82%
Jun 09, 2025
Fidelity Management & Research Company LLC
4.60M
9.5%
+647.11K
+16.38%
Mar 31, 2025
Armistice Capital LLC
1.95M
4.03%
+1.95M
--
Mar 31, 2025
JPL Investments SA
1.67M
3.46%
-12.28K
-0.73%
Mar 24, 2025
Vantage Consulting Group, Inc.
1.14M
2.36%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.03M
2.13%
-16.63K
-1.59%
Mar 31, 2025
The Vanguard Group, Inc.
892.12K
1.84%
+41.63K
+4.90%
Mar 31, 2025
Geode Capital Management, L.L.C.
473.61K
0.98%
+81.22K
+20.70%
Mar 31, 2025
Beetham (Peter Ronald)
382.44K
0.79%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.77%
+60.00K
+19.06%
Mar 24, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Proporção0.01%
iShares Russell 2000 Value ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
ProShares Hedge Replication ETF
Proporção0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
